Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Left Ventricular Systolic
Dongfeng Zhang1, Shuzheng Lyu2, Xiantao Song2
1Department of Cardiology, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Insights
For patients with coronary artery disease and left ventricular systolic dysfunction, coronary artery bypass grafting (CABG) shows long-term benefits over percutaneous coronary intervention (PCI). CABG significantly reduces long-term death, myocardial infarction, and repeat revascularization.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Optimal coronary revascularization strategy for patients with coronary artery disease (CAD) and left ventricular (LV) systolic dysfunction remains debated.
- Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are primary revascularization methods.
Purpose of the Study:
- To compare the efficacy and safety of CABG versus PCI in patients with CAD and LV systolic dysfunction.
- To evaluate long-term outcomes including mortality, myocardial infarction, and need for repeat revascularization.
Main Methods:
- A systematic meta-analysis was conducted.
- Searched PubMed, EMBASE, and Cochrane Controlled Trials Register for relevant studies.
- Included 4 prospective and 5 retrospective studies involving 6082 patients published before March 2015.
Main Results:
- CABG was associated with significantly lower long-term death (OR: 0.82, P = .01) compared to PCI.
- CABG demonstrated significantly lower rates of myocardial infarction (OR: 0.58, P = .03) and repeat revascularization (OR: 0.17, P < .001).
- Short-term mortality rates were comparable between CABG and PCI (OR: 2.09, P = .13).
Conclusions:
- Coronary artery bypass grafting offers significant long-term survival and clinical benefits over percutaneous coronary intervention in patients with CAD and LV systolic dysfunction.
- CABG is a preferred revascularization strategy for this patient population, considering long-term outcomes.
Abstract:
The optimal method of coronary revascularization for patients with coronary artery disease (CAD) and left ventricular (LV) systolic dysfunction is unclear. The purpose of this meta-analysis was to compare coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in these patients. Two investigators independently searched PubMed, EMBASE, and the Cochrane Controlled Trials Register databases for relevant studies. Four prospective and 5 retrospective studies, published before March 2015, involving 6082 patients were included. Compared with PCI, CABG was significantly associated with lower long-term death (odds ratio [OR]: 0.82, 95% confidence interval [CI]: 0.70-0.96, P = .01, I 2 = 0%), myocardial infarction (OR: 0.58, 95% CI: 0.36-0.95, P = .03, I 2 = 44%), and repeat revascularization (OR: 0.17, 95% CI: 0.14-0.22, P < .001, I 2 = 32%). The short-term death rate was comparable between CABG and PCI (OR: 2.09, 95% CI: 0.80-5.45, P = .13, I 2 = 9%). Coronary artery bypass grafting has long-term benefits compared with PCI in patients with CAD and LV dysfunction.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management


